What happened in optometry this week: February 5-February 9

Blog
Article

Catch up on what happened in optometry during the week of February 5-February 9.

Catch up with what Optometry Times shared this week:

FDA accepts IND for OK-101 for neuropathic corneal pain

By Emily Kaiser Maharjan, Assistant Managing Editor

OKYO Pharma announced the acceptance of OK-101 as an investigational new drug following clinical studies investigating the candidate in patients with neuropathic corneal pain, the first to do so.

Read here...

UC optometrists strike over “bad-faith” bargaining practices, protest low salaries

By Jordana Joy, Associate Editor

Members of the University Professional and Technical Employees CWA Local 9119 drew picket lines on February 6 and 7 to protest unfair labor and bargaining practices upheld by University of California.

Read here...

Gaps in vision screening for school-aged children uncovered in study

By Lynda Charters

A new study found that only a little over half of school-aged children participants underwent vision screening within the past two years, highlighting gaps in eye care access.

Read here...

Diagnosing and treating Demodex blepharitis

By Amy Nau, OD, Dipl CCLRT; Lynda Charters

Everything, no matter how minute, has a purpose and so that must also be the case for the pesky Demodex mite, the infective parasites that lie between or on the eyelashes in highly sebaceous areas. Some researchers think these parasites may help control bacterial populations through their acidic secretions. However, their waste can cause inflammation and hypersensitivity reactions in affected individuals.

Read here...

ALSTAR study identifies potential functional biomarker for early, intermediate AMD

By Lynda Charters

The study further defined the relationship between delayed rod-mediated dark adaptation and the status of outer retinal bands on optical coherence tomography.

Read here...

Recent Videos
The Vision Council CEO Ashley Mills overviews what is new and exciting at this year's show, running from February 19-22 in Orlando, Florida, and provides a free registration code for those still looking to register.
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Danica Marrelli, OD, FAAO, at Glaucoma 360 discussing visual field testing for patients with glaucoma
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Jeffrey Walline, OD, PhD, FAAO, gives an overview of the AAO's 2024 and what to expect in 2025 and beyond.
Dr Jamie Kuzniar discusses higher order aberrations and premium scleral lenses
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Sherrol Reynolds, OD, FAAO, values the ophthalmic-optometric collaboration on display at the summit, running from February 14-17, 2025 in San Juan, Puerto Rico.
© 2025 MJH Life Sciences

All rights reserved.